ATRYE Stock Overview
Provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Atrys Health, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €6.08 |
| 52 Week High | €6.82 |
| 52 Week Low | €5.74 |
| Beta | 0.45 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -10.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| ATRYE | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | -0.7% | -1.5% |
| 1Y | n/a | -24.7% | 3.5% |
Return vs Industry: Insufficient data to determine how ATRYE performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how ATRYE performed against the UK Market.
Price Volatility
| ATRYE volatility | |
|---|---|
| ATRYE Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: ATRYE has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ATRYE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 2,173 | Isabel Lozano Fernandez | www.atryshealth.com |
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
Atrys Health, S.A. Fundamentals Summary
| ATRYE fundamental statistics | |
|---|---|
| Market cap | €371.68m |
| Earnings (TTM) | -€23.21m |
| Revenue (TTM) | €191.83m |
1.9x
P/S Ratio-16.0x
P/E RatioIs ATRYE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ATRYE income statement (TTM) | |
|---|---|
| Revenue | €191.83m |
| Cost of Revenue | €121.58m |
| Gross Profit | €70.26m |
| Other Expenses | €93.47m |
| Earnings | -€23.21m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 36.62% |
| Net Profit Margin | -12.10% |
| Debt/Equity Ratio | 59.8% |
How did ATRYE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/05/30 13:26 |
| End of Day Share Price | 2023/03/02 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Atrys Health, S.A. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Luis Arredondo | Banco de Sabadell. S.A. |
| Victor Peiro Pérez | GVC Gaesco Valores |
| Joaquin Garcia-Quiros | JB Capital Markets |